Andrew Jack

1.4k total citations
58 papers, 1.0k citations indexed

About

Andrew Jack is a scholar working on Economics and Econometrics, Epidemiology and Pharmacology. According to data from OpenAlex, Andrew Jack has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 11 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Andrew Jack's work include Pharmaceutical industry and healthcare (9 papers), Pharmaceutical Economics and Policy (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Andrew Jack is often cited by papers focused on Pharmaceutical industry and healthcare (9 papers), Pharmaceutical Economics and Policy (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Andrew Jack collaborates with scholars based in United States, United Kingdom and Gambia. Andrew Jack's co-authors include Maimuna Mendy, N. Maine, A. Hall, H.C. Whittle, A. J. Hall, H Whittle, Simonetta Viviani, H Brincker, R. Cartwright and Ruggero Montesano and has published in prestigious journals such as The Lancet, The Lancet Oncology and The Journal of Infectious Diseases.

In The Last Decade

Andrew Jack

54 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Jack United States	15	499	361	191	183	115	58	1.0k
Andrea Marcellusi Italy	20	472 0.9×	172 0.5×	290 1.5×	114 0.6×	151 1.3×	157	1.5k
Francesco Saverio Mennini Italy	22	645 1.3×	180 0.5×	158 0.8×	113 0.6×	83 0.7×	141	1.5k
Helen E. Ownby United States	19	435 0.9×	333 0.9×	273 1.4×	102 0.6×	218 1.9×	33	1.6k
Mazen Hassanain Saudi Arabia	24	436 0.9×	499 1.4×	476 2.5×	71 0.4×	82 0.7×	98	2.1k
Jessica Howell Australia	23	966 1.9×	1.1k 2.9×	171 0.9×	95 0.5×	92 0.8×	91	1.6k
Claire Barber Canada	22	195 0.4×	63 0.2×	101 0.5×	146 0.8×	156 1.4×	109	1.5k
Peush ‎Sahni India	33	655 1.3×	452 1.3×	713 3.7×	56 0.3×	43 0.4×	238	3.1k
Aakash Desai United States	23	249 0.5×	145 0.4×	797 4.2×	170 0.9×	104 0.9×	139	1.9k
Kristien M.A.J. Tytgat Netherlands	22	230 0.5×	188 0.5×	696 3.6×	238 1.3×	173 1.5×	51	2.0k
Niraj J. Gusani United States	29	290 0.6×	285 0.8×	1.1k 5.5×	55 0.3×	39 0.3×	107	2.4k

Countries citing papers authored by Andrew Jack

Since Specialization

Citations

This map shows the geographic impact of Andrew Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Jack more than expected).

Fields of papers citing papers by Andrew Jack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Jack. The network helps show where Andrew Jack may publish in the future.

Co-authorship network of co-authors of Andrew Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Jack. A scholar is included among the top collaborators of Andrew Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Jack. Andrew Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haenlein, Michael & Andrew Jack. (2024). Measuring the long-term impact of business school research on academia, teaching, society and decision makers. International Journal of Research in Marketing. 42(1). 1–12. 5 indexed citations

Kickbusch, Ilona, Anurag Agrawal, Andrew Jack, Naomi Lee, & Richard Horton. (2019). Governing health futures 2030: growing up in a digital world—a joint The Lancet and Financial Times Commission. The Lancet. 394(10206). 1309–1309. 18 indexed citations

Rule, Simon, Paul D. Smith, Peter Johnson, et al.. (2015). The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial. Haematologica. 101(2). 235–240. 17 indexed citations

Wang, Han‐I, Eline Aas, Debra Howell, et al.. (2014). Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukemia: A Probabilistic Decision Model. Value in Health. 17(2). 205–214. 18 indexed citations

Jack, Andrew. (2014). US drug firm Pfizer seeks to buy UK company AstraZeneca. BMJ. 348(apr28 20). g2986–g2986. 1 indexed citations

Jack, Andrew. (2014). Drug patents cause fresh spat between South Africa and industry. BMJ. 348(feb07 4). g1377–g1377. 1 indexed citations

Jack, Andrew. (2014). Should healthcare be guaranteed for cancer but not diabetes?. BMJ. 348(mar04 15). g1812–g1812. 1 indexed citations

Jack, Andrew. (2013). Bring me sunshine: EU drug companies make payments to doctors public. BMJ. 347(jul05 2). f4342–f4342. 1 indexed citations

Jack, Andrew. (2013). Compound interests: how a partnership between academics and a drug company came unstuck. BMJ. 347(sep04 1). f5356–f5356. 1 indexed citations

10.

Jack, Andrew. (2012). "World's pharmacy" faces new challenges from Western drug companies. BMJ. 345(sep17 1). e6207–e6207. 2 indexed citations

11.

Jack, Andrew. (2012). Faking it. BMJ. 345(nov20 1). e7836–e7836. 2 indexed citations

12.

Jack, Andrew. (2012). Mea culpa: are multi-billion dollar fines forcing drug companies to clean up their act?. BMJ. 345(jul18 1). e4865–e4865. 1 indexed citations

13.

Jack, Andrew. (2008). Balancing Big Pharma’s books. BMJ. 336(7641). 418–419. 26 indexed citations

14.

Jack, Andrew. (2007). Obesity plan lacks foresight. The Lancet. 370(9598). 1528–1529. 2 indexed citations

15.

Bah, E., D. Maxwell Parkin, A. J. Hall, Andrew Jack, & H Whittle. (2001). Cancer in The Gambia: 1988–97. British Journal of Cancer. 84(9). 1207–1214. 63 indexed citations

16.

Cartwright, R., H Brincker, Paule‐Marie Carli, et al.. (1999). The rise in incidence of lymphomas in Europe 1985–1992. European Journal of Cancer. 35(4). 627–633. 143 indexed citations

17.

Viviani, Simonetta, Andrew Jack, A. J. Hall, et al.. (1999). Hepatitis B vaccination in infancy in The Gambia: protection. Vaccine. 17(23-24). 2946–2950. 120 indexed citations

18.

Jack, Andrew, A. Hall, N. Maine, Maimuna Mendy, & H.C. Whittle. (1999). What Level of Hepatitis B Antibody Is Protective?. The Journal of Infectious Diseases. 179(2). 489–492. 273 indexed citations

19.

Fortuin, M., J. Chotard, Andrew Jack, et al.. (1993). Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. The Lancet. 341(8853). 1129–1132. 79 indexed citations

20.

Jack, Andrew & David J. Bradley. (1991). Scales modified for dose determination in population-based chemotherapy. The Lancet. 337(8735). 219–221. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact